• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » Appeals court upholds Medtronic win in $6m legal fees spat with Mirowski

Appeals court upholds Medtronic win in $6m legal fees spat with Mirowski

April 4, 2017 By Brad Perriello

gavelThe estate of Dr. Michel Mirowski, who helped invent the implantable defibrillator owes Medtronic (NYSE:MDT) $6 million to cover legal fees in their long-running patent spat, a federal appeals court ruled today.

Mirowski Family Ventures represents the estate of CRM pioneer Dr. Michel Mirowski. The group, which controls several patents related to ICDs and cardiac resynchronization therapy devices, has been pursuing patent infringement cases against Medtronic, Guidant and successor Boston Scientific (NYSE:BSX) for years.

The case, which eventually found its way to the U.S. Supreme Court, dates its origins back to the early 1970s, when Mirowski licensed the patents to Eli Lilly (NYSE:LLY), then Medtronic’s main CRM competitor. (In 2004 the licenses passed to Lilly subsidiary Guidant, which Boston acquired in 2006.) In 2011, Judge Susan Robinson of the U.S. District Court for Delaware agreed with Medtronic’s bid to invalidate 1 of the patents; in 2015, after several rounds of appeals, Robinson ordered MFV to put up about $6 million to cover Medtronic’s legal fees.

MFV asked the U.S. Court of Appeals for the Federal Circuit to overturn that decision, arguing that its deal with Eli Lilly and later Guidant shouldn’t apply. If found liable for the fees, MFV argued, Boston Scientific and Guidant should also be found liable.

The Federal Circuit upheld the lower court’s judgment, ruling that the MFV-Lilly deal obligated the estate to cover Medtronic’s tab.

“We construe the legal effect of the [MFV-Lilly deal] to be that Mirowski Family Ventures assumed both Eli Lilly’s right to assert infringement against Medtronic and Eli Lilly’s obligation to pay Medtronic’s attorney fees if Medtronic was deemed the winning party in any resulting litigation. Therefore, the district court did not err in finding that Mirowski Family Ventures was bound by the fee shifting provision of the 1991 Agreement,” Judge Jimmie Reyna wrote for the appeals court.

Filed Under: Cardiovascular, Legal News, Patent Infringement Tagged With: Boston Scientific, Cardiac Rhythm Management, Eli Lilly & Co., Guidant Corp., Medtronic

More recent news

  • Comphya raises CHF 7.5 million for neurostim to treat ED
  • Fujifilm launches intelligent automation features for digital radiography
  • Integer appoints former iRhythm CEO to board
  • MMI debuts robotic surgery instruments, digital surgery platform
  • Synchrony Medical wins FDA nod for airway clearance system

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy